BIND Therapeutics

BIND Therapeutics

BIND Therapeutics

BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Suggest edits
Founded
2006
Raised
$37.9M
Follow us
Also headquartered in Cambridge
Companies in the same industry
Alexa global traffic share